Diabetes Devices Market Size Worth USD 67.39 Billion by 2034 | CAGR: 8.10%
The global diabetes devices market size is expected to reach USD 67.39 billion by 2034, according to a new study by Polaris Market Research. The report “Diabetes Devices Market Size, Share, Trends, Industry Analysis Report: By Type, Distribution Channel, End Use (Hospitals, Diagnostic Centers, and Homecare), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2026–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Diabetes devices help people suffering from diabetes monitor and maintain blood sugar levels, prevent severe complications, and generally improve the quality of life. This proactive approach enhances disease management, improves patient outcomes, and underscores the significant role these devices play in advancing patient care. The diabetes devices market demand is driven by the effectiveness of diabetes devices in reducing hospitalizations and mortality rates.
The incorporation of advanced technologies such as artificial intelligence (AI) and machine learning (ML) in diabetes devices majorly contributes to the growing diabetes devices market revenue. AI and ML help identify underlying risk factors, predict risk complications, and suggest interventions to prevent diabetes-related conditions, such as diabetic retinopathy and nephropathy. These technologies also play a crucial role in improving lifestyle management, fostering positive clinical decisions, and increasing patient engagement. For instance, a study published in the National Library of Medicine in August 2024 highlights how AI and machine learning are being increasingly utilized in diabetes management, significantly improving predictive accuracy, personalized treatment strategies, overall patient outcomes, and healthcare efficiency.
Request a free sample copy or read the full market insights : Diabetes Devices Market Report
Diabetes device manufacturers are expanding their presence into emerging markets due to factors such as a large elderly population, affordable healthcare, cost-effective labor, and less stringent regulations. Market participants are also capitalizing on technological advancements, including advanced insulin pumps and pens, to cater to the rising demand. For instance, in June 2022, Abbott launched a new continuous glucose and ketone monitoring system, further strengthening its position in the market.
Key Highlights of Diabetes Devices Market Report
- North America dominated the global market with 40.0% revenue share in 2025. This is attributed to the increasing aging population and rising prevalence of diabetes.
- The Asia Pacific diabetes devices industry is expected to register a significant CAGR of 9.0% during the forecast period. The presence of major market players and increasing prevalence of diabetes boost the growth.
- The insulin delivery devices segment is expected to witness CAGR of 8.0%. This is driven by rising technological advancements, such as insulin patches, pumps, and automated insulin delivery (AID) systems.
- The blood glucose monitoring (BGM) devices segment held 45.0% share in 2025. The growth is fueled by their affordability and precision in determining the body's glucose level.
- The hospital pharmacies segment held the largest market share of 50.0% in 2025. It is attributed to the growing use of continuous glucose monitoring devices for outpatient monitoring and ICU patients in hospitals.
- A few of the key players in the market are Abbott Diabetes Care; B Braun Melsungen AG; Biocorp; DexCom, Inc.; Johnson & Johnson; GlucoModicum; LifeScan Inc.; Medtronic PLC; Molex; Novo Nordisk; Phillips-Medisize; Roche Diabetes Care; Senseonics, Inc.; and Tandem Diabetes Care, Inc.
Polaris Market Research has segmented the diabetes devices market report on the basis of type, distribution channel, end use, and region:
By Type Outlook (Revenue – USD Billion, 2021–2034)
- BGM Devices
- Self-Monitoring Devices
- Blood Glucose Meters
- Testing Strips
- Lancets
- Continuous Glucose Monitoring Devices
- Sensors
- Transmitters
- Receiver
- Self-Monitoring Devices
- Insulin Delivery Devices
- Pumps
- Pens
- Syringes
- Jet Injectors
By Distribution Channel Outlook (Revenue – USD Billion, 2021–2034)
- Hospital pharmacies
- Retail Pharmacies
- Diabetes Clinics/Centers
- Online Pharmacies
- Others
By End Use Outlook (Revenue – USD Billion, 2021–2034)
- Hospitals
- Diagnostic Centers
- Homecare
By Regional Outlook (Revenue – USD Billion, 2021–2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Diabetes Devices Market Report Scope
| Report Attributes | Details |
| Market Size Value in 2025 | USD 33.32 billion |
| Market Size Value in 2026 | USD 36.0 billion |
| Revenue Forecast by 2034 | USD 67.39 billion |
| CAGR | 8.10% from 2026 to 2034 |
| Base Year | 2025 |
| Historical Data | 2021–20243 |
| Forecast Period | 2026–2034 |
| Quantitative Units | Revenue in USD Billion and CAGR from 2026 to 2034 |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Industry Trends |
| Segments Covered |
|
| Regional Scope |
|
| Competitive Landscape |
|
| Report Format |
|
| Customization | Report customization as per your requirements with respect to countries, regions, and segmentation. |
| For Specific Research Requirements |
Source: Polaris Market Research Analysis
